Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II

Peptides

Volumn 29, Issue 5, 2008, Pages 700-710

  Boivin, Stéphane ^a,b,c,d   Ségalas Milazzo, Isabelle ^a,b,c   Guilhaudis, Laure ^a,b,c   Oulyadi, Hassan ^a,b,c   Fournier, Alain ^d   Davoust, Daniel ^a,b,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b Normandie Université   (France)

^c IFRMP 23   (France)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Chemical shift perturbation; Interaction; NMR spectroscopy; Urotensin II; UT receptor

Indexed keywords

DODECYLPHOSPHORYLCHOLINE; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG; UROTENSIN 2 RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; MOLECULAR INTERACTION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; UROTENSINS;

EID: 42149126713     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.024     Document Type: Article

References (55)

1. Albert A.D., and Yeagle P.L. Domain approach to three-dimensional structure of rhodopsin using high-resolution nuclear magnetic resonance. Methods Enzymol 315 (2000) 107-115
2. Albert A.D., and Yeagle P.L. Structural studies on rhodopsin. Biochim Biophys Acta 1565 (2002) 183-195
3. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
4. Becker O.M., Marantz Y., Shacham S., Inbal B., Heifetz A., Kalid O., et al. G protein-coupled receptors: in silico drug discovery in 3D. Proc Natl Acad Sci USA 101 (2004) 11304-11309
5. Bern H.A., and Lederis K. A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts. J Endocrinol 45 Suppl (1969) xi-xii
6. Bern H.A., Pearson D., Larson B.A., and Nishioka R.S. Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes. Recent Prog Horm Res 41 (1985) 533-552
7. Boivin S., Guilhaudis L., Milazzo I., Oulyadi H., Davoust D., and Fournier A. Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide. Biochemistry 45 (2006) 5993-6002
8. Boucard A.A., Sauve S.S., Guillemette G., Escher E., and Leduc R. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. Biochem J 370 (2003) 829-838
9. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., and Karplus M. CHARMM: a program for macromolecular energy minimization and dynamics calculations. J Comput Chem 4 (1983) 187-217
10. Carotenuto A., Grieco P., Campiglia P., Novellino E., and Rovero P. Unraveling the active conformation of urotensin II. J Med Chem 47 (2004) 1652-1661
11. Chou K.C. Prediction of tight turns and their types in proteins. Anal Biochem 286 (2000) 1-16
12. Chung D.A., Zuiderweg E.R., Fowler C.B., Soyer O.S., Mosberg H.I., and Neubig R.R. NMR structure of the second intracellular loop of the alpha 2A adrenergic receptor: evidence for a novel cytoplasmic helix. Biochemistry 41 (2002) 3596-3604
13. Conlon J.M., O'Harte F., Smith D.D., Tonon M.C., and Vaudry H. Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem Biophys Res Commun 188 (1992) 578-583
14. Conlon J.M., Yano K., Waugh D., and Hazon N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 275 (1996) 226-238
15. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95 (1998) 15803-15808
16. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457 (1999) 28-32
17. Flohr S., Kurz M., Kostenis E., Brkovich A., Fournier A., and Klabunde T. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J Med Chem 45 (2002) 1799-1805
18. Foord S.M., Bonner T.I., Neubig R.R., Rosser E.M., Pin J.P., Davenport A.P., et al. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57 (2005) 279-288
19. Gendron G., Gobeil Jr. F., Belanger S., Gagnon S., Regoli D., and D'Orleans-Juste P. Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats. Peptides 26 (2005) 1468-1474
20. Giragossian C., Sugg E.E., Szwczyk J.R., and Mierke D.F. Intermolecular interactions between peptidic and non peptidic agonists and the third extracellular loop of the cholecystokinin 1 receptor. J Med Chem 46 (2003) 3476-3482
21. Giragossian C., Schaschke N., Moroder L., and Mierke D.F. Conformational and molecular modeling studies of β-cyclodextrin-heptagastrin and the third extracellular loop of the cholecystokinin 2 receptor. Biochemistry 43 (2004) 2724-2731
22. Grieco P., Carotenuto A., Patacchini R., Maggi C.A., Novellino E., and Rovero P. Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues. Bioorg Med Chem 10 (2002) 3731-3739
23. Grieco P., Rovero P., and Novellino E. Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor. Curr Med Chem 11 (2004) 969-979
24. Holleran B.J., Beaulieu M.E., Proulx C.D., Lavigne P., Escher E., and Leduc R. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites. Biochem J 402 (2007) 51-61
25. Katragadda M., Alderfer J.L., and Yeagle P.L. Solution structure of the loops of bacteriorhodopsin closely resembles the crystal structure. Biochim Biophys Acta 1466 (2000) 1-6
26. Kinney W.A., Almond Jr. H.R., Qi J., Smith C.E., Santulli R.J., de Garavilla L., et al. Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model. Angew Chem Int Ed Engl 41 (2002) 2940-2944
27. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14 (1996) 51-55 29-32
28. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst 24 (1991) 946-950
29. Labarrere P., Chatenet D., Leprince J., Marionneau C., Loirand G., Tonon M.C., et al. Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J Enzyme Inhib Med Chem 18 (2003) 77-88
30. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8 (1996) 477-486
31. Lavecchia A., Cosconati S., and Novellino E. Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists. J Med Chem 48 (2005) 2480-2492
32. Lawson Z., and Wheatley M. The third extracellular loop of G-protein-coupled receptors: more than just a linker between two important transmembrane helices. Biochem Soc Trans 32 (2004) 1048-1050
33. Li J., Edwards P.C., Burghammer M., Villa C., and Schertler G.F. Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 343 (2004) 1409-1438
34. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams Jr. D.L., et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266 (1999) 174-178
35. Ma D., Liu Z., Li L., Tang P., and Xu Y. Structure and dynamics of the second and third transmembrane domains of human glycine receptor. Biochemistry 44 (2005) 8790-8800
36. Marion D., Ikura M., Tschudin R., and Bax A. Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteins. J Magn Reson 85 (1989) 393-399
37. McKay R.T., Tripet B.P., Hodges R.S., and Sykes B.D. Interaction of the second binding region of troponin I with the regulatory domain of skeletal muscle Troponin C as determined by NMR spectroscopy. J Biol Chem 272 (1997) 28494-28500
38. Mierke D.F., and Giragossian C. Peptide hormone binding to G-protein-coupled receptors: structural characterization via NMR techniques. Med Res Rev 21 (2001) 450-471
39. Naider F., Khare S., Arshava B., Severino B., Russo J., and Becker J.M. Synthetic peptides as probes for conformational preferences of domains of membrane receptors. Biopolymers 80 (2004) 199-213
40. Nilges M., Gronenborn A.M., Brunger A.T., and Clore G.M. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. Protein Eng 2 (1988) 27-38
41. Nilges M. Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J Mol Biol 245 (1995) 645-660
42. Onan D., Hannan R.D., and Thomas W.G. Urotensin II: the old kid in town. Trends Endocrinol Metab 15 (2004) 175-182
43. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
44. Pebay-Peyroula E., Rummel G., Rosenbusch J.P., and Landau E.M. X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. Science 277 (1997) 1676-1681
45. Piotto M., Saudek V., and Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR 2 (1992) 661-665
46. Piserchio A., Bisello A., Rosenblatt M., Chorev M., and Mierke D.F. Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop. Biochemistry 39 (2000) 8153-8160
47. Reggio P.H. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J 8 (2006) E322-E336
48. Ruan K.H., So S.P., Wu J., Li D., Huang A., and Kung J. Solution structure of the second extracellular loop of human thromboxane A2 receptor. Biochemistry 40 (2001) 275-280
49. Salvatella X., and Giralt E. NMR-based methods and strategies for drug discovery. Chem Soc Rev 32 (2003) 365-372
50. So S.P., Wu J., Huang G., Huang A., Li D., and Ruan K.H. Identification of residues important for ligand binding of thromboxane A2 receptor in the second extracellular loop using the NMR experiment-guided mutagenesis approach. J Biol Chem 278 (2003) 10922-10927
51. Ulfers A.L., Piserchio A., and Mierke D.F. Extracellular domains of the neurokinin-1 receptor: structural characterization and interactions with substance P. Biopolymers 66 (2002) 339-349
52. Wishart D.S., Bigam C.G., Holm A., Hodges R.S., and Sykes B.D. 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR 5 (1995) 67-81
53. Wüthrich K. NMR of proteins and nucleic acids (1986), Wiley, New York
54. Zhang L., DeHaven R.N., and Goodman M. NMR and modeling studies of a synthetic extracellular loop II of the kappa opioid receptor in a DPC micelle. Biochemistry 41 (2002) 61-68
55. Zhu Y.C., Zhu Y.Z., and Moore P.K. The role of urotensin II in cardiovascular and renal physiology and diseases. Br J Pharmacol 148 (2006) 884-901